Ken Griffin Quidel Ortho Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$29.96 - $46.4 $1.17 Million - $1.81 Million	-39,100 Reduced 50.19%	38,800 $1.77 Million
Q2 2024 Aug 14, 2024	SELL	$32.9 - $47.0 $697,480 - $996,400	-21,200 Reduced 21.39%	77,900 $2.59 Million
Q1 2024 May 15, 2024	SELL	$41.76 - $74.73 $876,960 - $1.57 Million	-21,000 Reduced 17.49%	99,100 $4.75 Million
Q4 2023 Feb 14, 2024	BUY	$58.16 - $75.44 $709,552 - $920,368	12,200 Added 11.31%	120,100 $8.85 Million
Q3 2023 Nov 14, 2023	SELL	$70.9 - $88.63 $63,810 - $79,767	-900 Reduced 0.83%	107,900 $7.88 Million
Q2 2023 Aug 14, 2023	SELL	$81.09 - $94.16 $1.47 Million - $1.7 Million	-18,100 Reduced 14.26%	108,800 $9.02 Million
Q1 2023 May 15, 2023	BUY	$82.98 - $91.46 $871,290 - $960,329	10,500 Added 9.02%	126,900 $11.3 Million
Q4 2022 Feb 14, 2023	SELL	$66.93 - $97.5 $1.41 Million - $2.06 Million	-21,100 Reduced 15.35%	116,400 $9.97 Million
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $2.64 Million - $4.06 Million	37,720 Added 37.8%	137,500 $9.83 Million

291

67.5M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $3B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.